Showing results 9 to 10 of 10
< previous
Title | Author(s) | Issue Date | Views | |
---|---|---|---|---|
Pembrolizumab (MK-3475) vs Standard of Care Chemotherapy in Platinum Pretreated, Recurrent or Metastatic Nasopharyngeal Cancer: the Phase 2 Keynote-122 Study Proceeding/Conference:AHNS 9th International Conference of Head and Neck Cancer | 2016 | 48 | ||
Reporting Quality of Randomized, Controlled Trials Evaluating Combined Chemoradiotherapy in Nasopharyngeal Carcinoma Journal:International Journal of Radiation Oncology - Biology - Physics | 2017 | 37 |